3E Bioventures Capital L.P. 13D/13G Filings for Cytek Biosciences, Inc. (CTKB)

3E Bioventures Capital L.P. 13D and 13G filings for Cytek Biosciences, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-08-03
5:26 pm
Sale
2022-08-0313GCytek Biosciences, Inc.
CTKB
3E Bioventures Capital L.P.5,684,615
4.230%
-4,002,250decrease
(-41.32%)
Filing
2022-02-16
6:27 pm
Purchase
2021-12-3113GCytek Biosciences, Inc.
CTKB
3E Bioventures Capital L.P.9,686,865
7.240%
9,686,865increase
(New Position)
Filing